A | B | |||||
---|---|---|---|---|---|---|
Full study population | Asthma only (no COPD) | |||||
Mild to moderate (n = 17,934) | Severe (n = 790) | P-value | Mild to moderate (n = 16,142) | Severe (n = 561) | P-value | |
Respiratory related conditions | ||||||
Acute upper respiratory tract infections | 8472 (47.2) | 378 (47.8) | 0.765 | 7667 (47.5) | 271 (48.3) | 0.738 |
Rhinitis, any | 3924 (21.9) | 173 (21.9) | 1.000 | 3764 (23.3) | 133 (23.7) | 0.870 |
Chronic sinusitis | 204 (1.1) | 14 (1.8) | 0.145 | 176 (1.1) | 11 (2.0) | 0.085 |
Nasal polyps | 548 (3.1) | 42 (5.3) | 0.001 | 493 (3.1) | 33 (5.9) | <0.001 |
Acute lower respiratory infections | 4346 (24.2) | 204 (25.8) | 0.329 | 3609 (22.4) | 131 (23.3) | 0.615 |
Chronic bronchitis | 449 (2.5) | 32 (4.1) | 0.010 | 256 (1.6) | 15 (2.8) | 0.067 |
COPD | 1821 (10.2) | 171 (21.6) | <0.001 | 0 (0.0) | 0 (0.0) | 1.000 |
Influenza | 108 (0.6) | 10 (1.2) | 0.038 | 91 (0.6) | 6 (1.0) | 0.205 |
Pneumonia | 2574 (14.4) | 164 (20.7) | <0.001 | 2011 (12.5) | 93 (16.5) | 0.005 |
Other conditions | 8625 (48.1) | 392 (49.6) | 0.421 | 7143 (44.2) | 251 (44.7) | 0.852 |
Diabetes type 1 | 453 (2.5) | 18 (2.3) | 0.750 | 346 (2.1) | 13 (2.3) | 0.896 |
Diabetes type 2 | 1198 (6.7) | 54 (6.8) | 0.922 | 890 (5.5) | 34 (6.0) | 0.643 |
Arterial hypertension | 4450 (24.8) | 197 (25.0) | 0.971 | 3435 (21.3) | 117 (20.9) | 0.850 |
Ischaemic heart disease | 1332 (7.4) | 69 (8.7) | 0.195 | 903 (5.6) | 35 (6.2) | 0.576 |
Heart failure | 760 (4.2) | 47 (5.9) | 0.026 | 439 (2.7) | 17 (3.0) | 0.755 |
Malignant neoplasm | 20 (0.1) | 0 (0.0) | 0.702 | 15 (0.1) | 0 (0.0) | 0.996 |
Cerebrovascular diseases | 565 (3.2) | 29 (3.7) | 0.476 | 394 (2.4) | 15 (2.7) | 0.832 |
Anxiety and depression disorder | 3682 (20.5) | 161 (20.4) | 0.954 | 3198 (19.8) | 110 (19.6) | 0.948 |
Osteoporosis | 382 (2.1) | 22 (2.8) | 0.265 | 244 (1.5) | 10 (1.7) | 0.734 |
Inflammatory bowel disease | 607 (3.4) | 22 (2.8) | 0.415 | 526 (3.3) | 14 (2.4) | 0.377 |